Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System

NCT: NCT03714412 · WITHDRAWN

NCT IDNCT03714412
StatusWITHDRAWN
Start Date2019-09
Completion2023-12-15

Brief Summary

The study will test the safety and performance of the Cardiovalve transfemoral mitral valve replacement system in treating patients with severe mitral regurgitation who are at high risk for open chest surgery. The system is comprised of comprised of: 1) an Implant; 2) a Delivery System (DS); and 3) Accessories that are required for the implantation procedure. the procedure is performed under general anesthesia.

Frequently Asked Questions

What is Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System?

Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System is a clinical trial registered under NCT03714412. Current status: WITHDRAWN.

What is the status of NCT03714412?

The current status of NCT03714412 (Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System) is: WITHDRAWN.

When did Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System start?

Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System started on 2019-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑